Evidence and consensus-based recommendations reflects current knowledge about initiation of therapy
A Catalyst for Antiphospholipid Syndrome Research
APS ACTION is coordinating international efforts to study this rare and potentially fatal autoimmune disorder
New Approaches to Inflammatory Myopathy
Advances in diagnostic modalities and treatments emerge
Letter to the Editor
Feedback from our Readers
No Clear Connection Between Inflammation & Disease Progression in AS
TNF blockers decrease symptoms but seem to have little impact on structural damage
The Expanded Role of the Inflammasome in Human Disease
Exploring advances, evaluating what remains to be done
Decoding Autoinflammatory Syndromes
Understanding the genetic basis of errors of the immune system may provide new opportunities for therapy
Psoriatic Arthritis: From Leeds to the Limelight
Advances in understanding of the disease begin in the 1960s
Juvenile Idiopathic Arthritis
Patient Fact Sheet
Antiphospholipid Syndrome
Antiphospholipid syndrome (APS) is an autoimmune disease associated with frequent clotting in arteries and veins and fetal losses. The clotting results from the presence of proteins in the blood—called antiphospholipid autoantibodies (aPL)—formed against the person’s own tissues.